FDA Indicates Optimism Prevnar 13 Will Show Clinical Benefit In Confirmatory Trial
Advisory committee votes 14-1 in favor of effectiveness and safety in adults 50 and older.
Advisory committee votes 14-1 in favor of effectiveness and safety in adults 50 and older.